191. Werner syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 3 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathways : 6
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Growth hormone
National Center for Research Resources (NCRR)
1992 - NCT00004815 -
Nicotinamide riboside
Yokote Koutaro
2021 Phase 1-2 JPRN-jRCTs031190141 -
Progerinin
PRG Science & Technology Co., Ltd.
2025 Phase 2 NCT05847179 -
2020 Phase 1 NCT04512963 United States
National Center for Research Resources (NCRR)
1992 - NCT00004815 -
Nicotinamide riboside
Yokote Koutaro
2021 Phase 1-2 JPRN-jRCTs031190141 -
Progerinin
PRG Science & Technology Co., Ltd.
2025 Phase 2 NCT05847179 -
2020 Phase 1 NCT04512963 United States